CytoMed Therapeutics Bids for TC BioPharm Assets
Ticker: GDTC · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1873093
| Field | Detail |
|---|---|
| Company | Cytomed Therapeutics LTD (GDTC) |
| Form Type | 6-K |
| Filed Date | Oct 14, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, administration, press-release
TL;DR
CytoMed Therapeutics makes an undisclosed cash bid for TC BioPharm's assets after TCBL entered administration.
AI Summary
On October 14, 2025, CytoMed Therapeutics Limited announced it has submitted an undisclosed cash bid for potentially synergistic assets of TC BioPharm Limited (TCBL). TCBL entered administration on October 2, 2025. This filing is a report of this potential acquisition activity.
Why It Matters
This potential acquisition could significantly alter the competitive landscape and asset base for both companies in the pharmaceutical preparations sector.
Risk Assessment
Risk Level: medium — The undisclosed sum and the administration status of TC BioPharm introduce uncertainty regarding the deal's value and completion.
Key Players & Entities
- CytoMed Therapeutics Limited (company) — Filer and bidder
- TC BioPharm Limited (company) — Target company in administration
- October 14, 2025 (date) — Date of press release and bid submission
- October 2, 2025 (date) — Date TC BioPharm Limited entered administration
FAQ
What is the specific dollar amount of CytoMed Therapeutics' cash bid for TC BioPharm Limited's assets?
The filing states that the cash bid is of an undisclosed sum.
When did TC BioPharm Limited enter administration?
TC BioPharm Limited entered administration on October 2, 2025.
What is the nature of the assets CytoMed Therapeutics is interested in acquiring from TC BioPharm?
CytoMed Therapeutics is interested in potentially synergistic assets of TC BioPharm Limited.
What form does this SEC filing take?
This is a Form 6-K report of a foreign private issuer.
What is the primary business of CytoMed Therapeutics Ltd?
CytoMed Therapeutics Ltd is in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Stats: 235 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2025-10-14 08:00:17
Filing Documents
- form6-k.htm (6-K) — 17KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-25-017923.txt ( ) — 40KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CytoMed Therapeutics Limited By: /s/ CHOO Chee Kong Name: CHOO Chee Kong Date: October 14, 2025 Title: Director and Chairman